| Availability: | |
|---|---|
1. Surpassing Manual Annotation Limits for Precise Identification of Complex Cells
We adopt mIF + H&E dual staining + AI analysis technology to overcome challenges that traditional pathology cannot address:
Precise differentiation of lymphocyte subsets: Through multi-target mIF staining (e.g., CD3+ T cells and CD20+ B cells) combined with AI spatial co-localization analysis, lymphocyte subsets are accurately distinguished in H&E-stained sections (accuracy > 95%).
Dynamic recognition of cell states: Integrating functional markers (Ki-67/Cleaved Caspase-3/PD-1) with morphological features, AI automatically quantifies states such as apoptosis, proliferation, and exhaustion.
Efficient capture of rare cells: AI, via million-level cell scanning and weak signal enhancement algorithms, achieves a detection sensitivity of 0.1% (easily missed by manual inspection).
2. Dual Staining Technology for Ultra-High Precision
Dual staining technology: Cells stained with H&E are annotated via mIF staining.
Objective cell annotation technology: Not based on the subjective annotation of pathologists.
mIF-specific labeling: Precisely identifies target cells (e.g., tumor cells, immune cells).
H&E morphological verification: Dual validation ensures annotation reliability.
AI automatic registration: Eliminates staining position deviations with an accuracy of > 98%.
3. High Cost-Effectiveness, Saving 50% of Costs
AI automation: Reduces manual time by 80%.
Batch processing: Capable of completing annotation and analysis of 200+ samples per day.
Flexible customization: Supports special labeling schemes and data analysis requirements.
Technical Advantages
Objective cell annotation technology: Not based on the subjective annotation of pathologists.
Multi-dimensional verification: Dual confirmation with molecular markers + morphology.
Intelligent anti-interference: Automatically corrects issues like uneven staining and tissue folding.
Traceable standards: Fully digitalized process with reproducible results.
Typical Cases
Assisted a research team in annotating over 18 cell types, 70 million cells, and 30 tissue types.
A pharmaceutical company completed drug screening analysis of 1000+ samples in 5 days (traditionally requiring 3 weeks).